Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Caitlin C Ten Lohuis"'
Autor:
Caitlin C. ten Lohuis, MSN, ACNP-BC, Sarah C. Burke, MD, Cooper J. Jannuzzo, MS, Nicholas A. Barker, PharmD, Edward P. Chen, MD, Laurence W. Busse, MD, MBA, FCCM
Publikováno v:
Critical Care Explorations, Vol 4, Iss 5, p e0687 (2022)
OBJECTIVES:. Catecholamines and vasopressin are commonly used in patients with post cardiovascular surgery vasoplegia (PCSV). Multimodal therapy, including methylene blue (MB), hydroxocobalamin, and angiotensin II (Ang II), may improve outcomes in pa
Externí odkaz:
https://doaj.org/article/d5551c05fe56413b81c7bba294b7d5e2
Autor:
Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Adam S. Lauring, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Jennie H. Kwon, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Meredith McMorrow, Diya Surie, Wesley H. Self, Manish M. Patel
Publikováno v:
Vaccine, vol 40, iss 48
BackgroundTest-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3d4d9eebaaa287a091629da3368667
https://doi.org/10.1016/j.vaccine.2022.10.034
https://doi.org/10.1016/j.vaccine.2022.10.034
Autor:
Nathaniel M, Lewis, Wesley H, Self, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H, Keipp Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Shekhar A, Ghamande, Tresa A, McNeal, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Laurence W, Busse, Caitlin C Ten, Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Jillian P, Rhoads, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Katherine, Adams, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Clinical Infectious Diseases. 75:S159-S166
Background . Adults in the United States (US) began receiving the adenovirus vector coronavirus disease 2019 (COVID-19) vaccine, Ad26.COV2.S (Johnson & Johnson [Janssen]), in February 2021. We evaluated Ad26.COV2.S vaccine effectiveness (VE) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4efe6f52aace78e5793a53d83a0ad8
https://doi.org/10.1093/cid/ciac439
https://doi.org/10.1093/cid/ciac439
Autor:
Patrick M. Wieruszewski, Troy G. Seelhammer, Erin F. Barreto, Laurence W. Busse, Jonathan H. Chow, Danielle L. Davison, Bhavita Gaglani, Ashish K. Khanna, Caitlin C. ten Lohuis, Kristin C. Mara, Erica D. Wittwer
Publikováno v:
Journal of intensive care medicine.
Background: Patients supported on mechanical circulatory support devices experience vasodilatory hypotension due to high surface area exposure to nonbiological and non-endothelialized surfaces. Angiotensin II has been studied in general settings of v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e050339f92570a4b8a10f72ca612199
https://pubmed.ncbi.nlm.nih.gov/36524274
https://pubmed.ncbi.nlm.nih.gov/36524274
Autor:
Anne Zepeski, Catherine L. Hough, Wesley H. Self, Ian Jones, Amira Mohamed, Tresa McNeal, Samuel M. Brown, Shekhar Ghamande, Jennifer G. Wilson, Alexandra June Gordon, Eric A. Naioti, Manjusha Gaglani, Jay S. Steingrub, Steven Y. Chang, Natalie J. Thornburg, Yuwei Zhu, Adrienne Baughman, Mark W Tenforde, Matthew E. Prekker, Christopher J. Lindsell, William B. Stubblefield, Arnold S. Monto, Nida Qadir, James D. Chappell, Nicholas M. Mohr, Carolina Rivas, Sandra N. Lester, Abhijit Duggal, Ithan D. Peltan, Kevin W Gibbs, Jillian P. Rhoads, Jennifer R. Verani, Miwako Kobayashi, Hilary M. Babcock, Manish M. Patel, Arber Shehu, Emily T. Martin, Natasha B. Halasa, Laurence W. Busse, Megan M. Stump, Jennie H. Kwon, David J. Douin, Daniel J. Henning, Matthew C. Exline, Kelsey N Womack, Michelle N. Gong, Todd W. Rice, Samantha M. Olson, H. Keipp Talbot, Adam S. Lauring, Jonathan D Casey, Adit A. Ginde, Kimberly W. Hart, Heidi L Erickson, D. Clark Files, David N. Hager, Carlos G. Grijalva, Lisa Mills, Christopher Mallow, Akram Khan, Caitlin C Ten Lohuis
Publikováno v:
Morbidity and Mortality Weekly Report
Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3695ec34b8521f85c10fe2b51a1b6080
https://doi.org/10.15585/mmwr.mm7038e1
https://doi.org/10.15585/mmwr.mm7038e1
Autor:
Katherine Adams, Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David Huynh, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, Madeline Hicks, David N. Hager, Harith Ali, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Arnold S. Monto, Adam S. Lauring, Akram Khan, Catherine L. Hough, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Hilary M. Babcock, Jennie H. Kwon, James D. Chappell, Natasha Halasa, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Christopher J. Lindsell, Kimberly W. Hart, Sandra N. Lester, Natalie J. Thornburg, SoHee Park, Meredith L. McMorrow, Manish M. Patel, Mark W. Tenforde, Wesley H. Self
Publikováno v:
medRxiv
To compare the effectiveness of a primary covid-19 vaccine series plus booster doses with a primary series alone for the prevention of hospital admission with omicron related covid-19 in the United States.Multicenter observational case-control study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e0aea8d33df92e3efc865bd23c2488
https://doi.org/10.1101/2022.06.09.22276228
https://doi.org/10.1101/2022.06.09.22276228
Autor:
Amira Mohamed, Catherine L. Hough, Manjusha Gaglani, Nathan I. Shapiro, Samantha M. Olson, Abhijit Duggal, Arber Shehu, Manish M. Patel, Kimberly W. Hart, Laurence W. Busse, William B Stubblefield, Emily T. Martin, Ithan D. Peltan, Caitlin C Ten Lohuis, Kevin W Gibbs, Jillian P. Rhoads, Mark W Tenforde, Tresa McNeal, Miwako Kobayashi, Jennifer G. Wilson, Christopher J. Lindsell, Alexandra June Gordon, Kelsey N Womack, Steven Y. Chang, Jay S. Steingrub, Samuel M. Brown, Anne Zepeski, Carolina Rivas, Daniel J. Henning, Jennie H. Kwon, Christopher Mallow, Michelle N. Gong, Shekhar Ghamande, Todd W. Rice, Adrienne Baughman, Influenza, Jennifer R. Verani, Arnold S. Monto, Nida Qadir, James D. Chappell, Akram Khan, Nicholas M. Mohr, Natasha B. Halasa, H. Keipp Talbot, Hilary M. Babcock, David J. Douin, Yuwei Zhu, Carlos G. Grijalva, Matthew E. Prekker, Wesley H. Self, D. Clark Files, David N. Hager, Katherine Adams, Adam S. Lauring, Ian Jones, Matthew C. Exline, Heidi L Erickson, Jonathan D Casey, Adit A. Ginde
Publikováno v:
JAMA
IMPORTANCE: A comprehensive understanding of the benefits of COVID-19 vaccination requires consideration of disease attenuation, determined as whether people who develop COVID-19 despite vaccination have lower disease severity than unvaccinated peopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0de4b15d4eaf88d751fd07e65278925
https://europepmc.org/articles/PMC8569602/
https://europepmc.org/articles/PMC8569602/
Autor:
Wesley H. Self, Jennifer R. Verani, Caitlin C Ten Lohuis, Abhijit Duggal, Hayley B. Gershengorn, Matthew E. Prekker, Natasha B. Halasa, Laurence W. Busse, Christopher J. Lindsell, Samuel M. Brown, Ian Jones, Christopher Mallow, Emily T. Martin, Adrienne Baughman, Akram Khan, Amira Mohamed, Kevin W Gibbs, Ithan D. Peltan, Tresa McNeal, Carlos G. Grijalva, Miwako Kobayashi, Arber Shehu, Shekhar Ghamande, Adam S. Lauring, Matthew C. Exline, Jonathan D Casey, William B Stubblefield, Jennifer G. Wilson, Alexandra June Gordon, Jennie H. Kwon, Michelle N. Gong, Todd W. Rice, Kelsey N Womack, Steven Y. Chang, Adit A. Ginde, Daniel J. Henning, Heidi L Erickson, Nathan I. Shapiro, D. Clark Files, David N. Hager, Samantha M. Olson, Stephanie J. Schrag, H. Keipp Talbot, Anne Zepeski, Mark W Tenforde, David J. Douin, Influenza, Yuwei Zhu, Nicholas M. Mohr, Manish M. Patel, Kimberly W. Hart, Jay S. Steingrub, Meagan Stephenson, Manjusha Gaglani, C Terri Hough, Arnold S. Monto, Nida Qadir, James D. Chappell, Hilary M. Babcock
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundAs SARS-CoV-2 vaccination coverage increases in the United States (US), there is a need to understand the real-world effectiveness against severe Covid-19 and among people at increased risk for poor outcomes.MethodsIn a multicenter case-con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114ab165f1aa423e0425fea0cccb4118
https://doi.org/10.1101/2021.07.08.21259776
https://doi.org/10.1101/2021.07.08.21259776
Autor:
Mark W, Tenforde, Manish M, Patel, Adit A, Ginde, David J, Douin, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Manjusha, Gaglani, Tresa, McNeal, Shekhar, Ghamande, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Matthew C, Exline, Michelle N, Gong, Amira, Mohamed, Daniel J, Henning, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Catherine L, Hough, Laurence W, Busse, Caitlin C, Ten Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Hayley B, Gershengorn, Hilary M, Babcock, Jennie H, Kwon, Natasha, Halasa, James D, Chappell, Adam S, Lauring, Carlos G, Grijalva, Todd W, Rice, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Samantha M, Olson, Meagan, Stephenson, Stephanie J, Schrag, Miwako, Kobayashi, Jennifer R, Verani, Wesley H, Self
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 74(9)
Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination coverage increases in the United States, there is a need to understand the real-world effectiveness against severe coronavirus disease 2019 (COVID-19) and among pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285d00858317831a20b618abd467c363
https://pubmed.ncbi.nlm.nih.gov/34268515
https://pubmed.ncbi.nlm.nih.gov/34268515
Autor:
Adam S Lauring, Mark W Tenforde, James D Chappell, Manjusha Gaglani, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Nathan I Shapiro, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Matthew C Exline, Michelle N Gong, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin C ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Alexandra June Gordon, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Natasha Halasa, Carlos G Grijalva, Todd W Rice, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Jillian P Rhoads, Christopher J Lindsell, Kimberly W Hart, Yuwei Zhu, Katherine Adams, Stephanie J Schrag, Samantha M Olson, Miwako Kobayashi, Jennifer R Verani, Manish M Patel, Wesley H Self
Publikováno v:
BMJ. :e069761
ObjectivesTo characterize the clinical severity of covid-19 associated with the alpha, delta, and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the effectiveness of mRNA vaccines to prevent hospital admissions related t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fedb6b83ed08c87cee740e32562eb2be
https://doi.org/10.1136/bmj-2021-069761
https://doi.org/10.1136/bmj-2021-069761